NASHUA,
N.H. (November 6, 2018) –  iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader
providing innovative cancer detection and therapy solutions,
today announced that it will
release financial results for the third quarter and nine months ended September
30, 2018 after the close of the market and host a conference call at 4:30pm
Eastern Time on Tuesday, November 13th.

 

Tuesday, November
13th @ 4:30 pm Eastern Time

Domestic: 888-599-8686

International: 323-994-2093

Conference ID: 1529049

Webcast: http://public.viavid.com/index.php?id=131972

 

Replays
available through November 27th:

Domestic: 844-512-2921

International: 412-317-6671

Replay
PIN: 1529049

 

In
addition, a replay of the call will remain on the Company’s website (www.icadmed.com)
until the Company releases its fourth quarter and year ended 2018 financial
results. 

 

About iCAD, Inc.

 

Headquartered in Nashua, NH,
iCAD is a global medical technology leader providing innovative cancer
detection and therapy solutions. For more information, visit 
www.icadmed.com.

 

Contact:

 

Media
Inquiries:

ARPR,
on behalf of iCAD, Inc.

Paul Barren

(855) 300-8209

paul@arpr.com

 

or

 

Investor
Relations:

LifeSci
Advisors

Jeremy
Feffer

(212)
915-2568

jeremy@lifesciadvisors.com